XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 93 filers reported holding XENON PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $2,586,000 | -6.0% | 85,000 | -52.8% | 0.94% | +85.2% |
Q3 2021 | $2,750,000 | +1378.5% | 180,000 | +1636.6% | 0.51% | +1651.7% |
Q1 2021 | $186,000 | -82.4% | 10,365 | -87.0% | 0.03% | -87.1% |
Q3 2018 | $1,056,000 | +420.2% | 80,000 | +220.0% | 0.22% | +215.5% |
Q3 2016 | $203,000 | – | 25,000 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |